Ra Seung Won, Kwon Yong Soo, Yoon Sung Ho, Jung Chi Young, Kim Jusang, Choi Hye Sook, Sheen Seung Soo, Hwang Hun Gyu, Lee Ji-Hyun, Kim Tae-Hyung
Department of Medicine, Division of Pulmonology, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, South Korea.
Department of Medicine, Division of Pulmonology, Chonnam National University Hospital, Gwangju, South Korea.
Clin Respir J. 2018 Apr;12(4):1424-1432. doi: 10.1111/crj.12671. Epub 2017 Aug 11.
Presence of purulent sputum during an acute exacerbation of chronic obstructive pulmonary disease (AECOPD) is considered sufficient indication for starting empirical antibiotics. We investigated the relationship between detection of potentially pathogenic bacteria (PPB) using sputum culture or polymerase chain reaction (PCR) and clinical response and sought the risk factors for PPB growth.
In 342 outpatients with AECOPD, we compared detection rates of H. influenzae (HI) and S. pneumoniae (SP) using conventional sputum culture versus PCR. The utility of either technique to predict clinical cure or failure after effective antibiotics was assessed. The factors predicting positive sputum cultures were evaluated using logistic regression.
Using sputum culture, 132 PPB were detected. The predominant bacteria were HI (40.9%) and SP (19.7%). Detection of HI or SP in sputum was higher using PCR than culture growth (60.8% vs 18.6%; P < .001). Clinical response was not affected by the results of either technique. Independent risk factors for PPB isolation were Gram-negative bacteria on sputum smear (OR 15.78, 95% CI 6.38-39.06; P < .001), sputum purulence (OR 2.31, 95% CI, 1.05-5.11; P = .04), body temperature (OR 0.16, 95% CI 0.05-0.54; P = .003), albumin level (OR 0.29, 95% CI 0.09-0.88; P = .03) and dyspnea grade (OR 0.51, 95% CI 0.27-0.96; P = .04).
Neither culture growth nor PCR positivity for HI or SP in sputum predicted clinical response to antibiotics; therefore, these tests are not necessary for outpatients with AECOPD. Examining Gram-staining and purulence on sputum smear, however, was significant to predict PPB growth in sputum.
在慢性阻塞性肺疾病急性加重期(AECOPD)期间出现脓性痰被认为是开始经验性使用抗生素的充分指征。我们研究了使用痰培养或聚合酶链反应(PCR)检测潜在病原菌(PPB)与临床反应之间的关系,并寻找PPB生长的危险因素。
在342例AECOPD门诊患者中,我们比较了使用传统痰培养与PCR检测流感嗜血杆菌(HI)和肺炎链球菌(SP)的检出率。评估了这两种技术在有效使用抗生素后预测临床治愈或失败的效用。使用逻辑回归评估预测痰培养阳性的因素。
使用痰培养,检测到132株PPB。主要细菌为HI(40.9%)和SP(19.7%)。使用PCR检测痰中HI或SP的检出率高于培养生长(60.8%对18.6%;P <.001)。两种技术的结果均未影响临床反应。PPB分离的独立危险因素为痰涂片革兰氏阴性菌(比值比15.78,95%置信区间6.38 - 39.06;P <.001)、痰脓性(比值比2.31,95%置信区间1.05 - 5.11;P = 0.04)、体温(比值比0.16,95%置信区间0.05 - 0.54;P = 0.003)、白蛋白水平(比值比0.29,95%置信区间0.09 - 0.88;P = 0.03)和呼吸困难分级(比值比0.51,95%置信区间0.27 - 0.96;P = 0.04)。
痰中HI或SP的培养生长或PCR阳性均不能预测对抗生素的临床反应;因此,对于AECOPD门诊患者,这些检测并非必要。然而,检查痰涂片的革兰氏染色和脓性对预测痰中PPB生长具有重要意义。